Cellular ‘Overflow Valve’ Linked to Parkinson’s Disease Offers New Therapeutic Target
Researchers have identified a crucial ion channel, TMEM175, within cells that functions like an “overflow valve” in the cellular recycling system. This discovery, published in PNAS (Proceedings of the National Academy of Sciences) on March 26, 2026, sheds light on the mechanisms behind Parkinson’s disease and opens avenues for novel therapies.
Lysosomes: The Cell’s Recycling Centers
Lysosomes are essential compartments within cells responsible for breaking down waste materials and reusing their components. To function effectively, lysosomes must maintain a specific acidic environment. This acidity is created by proteins that pump protons (H+) into the lysosomes, but maintaining the correct balance requires additional proteins embedded in the lysosomal membrane.
TMEM175: A Key Regulator of Acidity
The study, led by Professor Christian Grimm (LMU Munich) and Dr. Oliver Rauh (Bonn-Rhein-Sieg University of Applied Sciences), reveals that the TMEM175 ion channel plays a critical role in regulating this acidity. Researchers found that TMEM175 acts as an overflow valve, preventing the lysosome from becoming excessively acidic. When TMEM175 is faulty or disrupted, pH regulation is impaired, leading to a buildup of undegraded proteins and potentially contributing to the development of neurodegenerative diseases like Parkinson’s disease [1].
Unraveling the Function of TMEM175
For years, the precise function of TMEM175 remained a mystery. Researchers at Hochschule Bonn-Rhein-Sieg, LMU Munich, TU Darmstadt, and Nanion Technologies collaborated to decipher its role. Their work demonstrates that TMEM175 not only transports potassium ions but also protons, directly influencing the pH level within lysosomes [2]. Using the patch-clamp method, the team observed that TMEM175 adjusts proton flow based on acidity levels, maintaining optimal conditions for waste breakdown.
Implications for Parkinson’s Disease
Previous research has established a link between lysosomal dysfunction and neurodegenerative diseases, including Parkinson’s. This new study solidifies the role of TMEM175 in this process. “Our study establishes that the ion channel TMEM175 plays a decisive role here,” says Dr. Oliver Rauh [2]. By understanding how TMEM175 regulates lysosomal acidity, scientists have identified a promising target for developing drugs to treat or prevent Parkinson’s disease [3], [4].
Future Directions
The discovery of TMEM175’s function provides a crucial foundation for further research into lysosomal function and the development of targeted therapies for neurodegenerative diseases. Further investigation will focus on understanding the specific mechanisms by which TMEM175 dysfunction contributes to Parkinson’s disease and exploring potential drug candidates that can restore its proper function.